FDA infection control

Global demand for infection control technologies has intensified as healthcare systems confront persistent risks from healthcare-associated infections, antimicrobial resistance, and emerging pathogens. The COVID-19 pandemic accelerated the adoption of advanced sterilization, disinfection, and monitoring solutions, but sustained demand now reflects structural shifts in hospital protocols, regulatory expectations, and patient safety standards across the United States … Read more